Gene Weaver

Startup

Gene Weaver is a Cambridge-based biology technology leader driving the development of next generation gene modification tools. Founded in mid-2023 by Recombinase Polymerase Amplification (RPA) technology inventor Dr Niall Armes, the interdisciplinary team of protein engineers, cell biologist, bioinformaticians, is employing a unique enzymatic system with the potential to transform gene editing.

By employing a unique naturally derived enzymatic system, the Gene Weaver Technology Platform will allow large edits to be made in a controlled way, efficiently.

The cost of manufacturing will also be reduced by enhancing the durability of the gene insertion step. Together, these will make the genetic medicine revolution available to a broader patient population, including those in low- and middle-income countries (LMIC).